Tenacia and Golden Age Health Partner to Commercialise Ztalmy for CDKL5 Deficiency Disorder in China
Tenacia Biopharmaceuticals has granted Golden Age Health exclusive rights to commercialise Ztalmy, the first approved therapy for CDKL5 deficiency disorder, in Mainland China.
Bain Capital | 03/02/2026 | By News Bureau | 139
Centrient Pharmaceuticals Appoints New Site Director for Delft Facility
Centrient Pharmaceuticals has announced the appointment of Pierre-Yves Dalla-Libera as the new Site Director for its Delft facility, effective September 1, 2025.
Bain Capital | 10/07/2025 | By Dineshwori | 606
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
As an independent company, Tanabe Pharma will continue to build on its legacy of medical innovation while developing new opportunities for growth through business development, licensing activities, enhanced R&D productivity, commercialization and strategic acquisitions.
Bain Capital | 10/02/2025 | By Aishwarya | 397
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy